Logo image of DMYY

DMY SQUARED TECHNOLOGY GR-A (DMYY) Stock Fundamental Analysis

USA - NYSEARCA:DMYY - US2332761046 - Common Stock

13.79 USD
+0.44 (+3.3%)
Last: 9/19/2025, 8:04:02 PM
13.75 USD
-0.04 (-0.29%)
After Hours: 9/19/2025, 8:04:02 PM
Fundamental Rating

0

DMYY gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. DMYY may be in some trouble as it scores bad on both profitability and health. DMYY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DMYY has reported negative net income.
DMYY had a negative operating cash flow in the past year.
DMYY Yearly Net Income VS EBIT VS OCF VS FCFDMYY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -19.57%
ROE -36.97%
ROIC N/A
ROA(3y)-1.13%
ROA(5y)N/A
ROE(3y)-1.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DMYY Yearly ROA, ROE, ROICDMYY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 2 -2 -4

1.3 Margins

DMYY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DMYY Yearly Profit, Operating, Gross MarginsDMYY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for DMYY has been reduced compared to 1 year ago.
The debt/assets ratio for DMYY is higher compared to a year ago.
DMYY Yearly Shares OutstandingDMYY Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
DMYY Yearly Total Debt VS Total AssetsDMYY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

DMYY has an Altman-Z score of 1.58. This is a bad value and indicates that DMYY is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.12 indicates that DMYY is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACCN/A
WACCN/A
DMYY Yearly LT Debt VS Equity VS FCFDMYY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

DMYY has a Current Ratio of 0.10. This is a bad value and indicates that DMYY is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.10 indicates that DMYY may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
DMYY Yearly Current Assets VS Current LiabilitesDMYY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DMYY have decreased strongly by -831.37% in the last year.
EPS 1Y (TTM)-831.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2695.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DMYY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DMYY Price Earnings VS Forward Price EarningsDMYY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DMYY Per share dataDMYY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DMYY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DMY SQUARED TECHNOLOGY GR-A

NYSEARCA:DMYY (9/19/2025, 8:04:02 PM)

After market: 13.75 -0.04 (-0.29%)

13.79

+0.44 (+3.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners56.3%
Inst Owner Change-47.96%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap54.06M
AnalystsN/A
Price TargetN/A
Short Float %0.52%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.84
P/tB 3.84
EV/EBITDA N/A
EPS(TTM)-1.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0
BVpS3.59
TBVpS3.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.57%
ROE -36.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.13%
ROA(5y)N/A
ROE(3y)-1.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 1.58
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-831.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2695.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.02%
OCF growth 3YN/A
OCF growth 5YN/A